HISTOGENESIS OF LUNG CANCER - STAGES OF INVESTIGATION
DOI:
https://doi.org/10.11603/mie.1996-1960.2022.3.13371Keywords:
lung cancer, histogenesis, growth in alveoliAbstract
Background. Lung cancer (LC) is the most common malignant tumor in humans. The clinical course of this disease is characterized by late diagnosis, high mortality and poor prognosis. Studing the histogenesis of LC will reveal the features of initial and prolonged growth and explain the mentioned state of the problem. The aim: to determine the histogenesis, features of growth and histological structure of LC.
Material and methods. The operative material of 120 patients with LC was studied. Histological preparations stained with hematoxylin and eosin and by the Papanicolaou method were studied. Different levels of proliferative activity of LC cells were determined by a number of morphological features and by immunohistochemical indicators with monoclonal antibodies - Ki67; PCNA. Histological studies were performed at magnifications: X200; X400; X1000.
Results. The study of histological preparations of LC, which are most often found in oncology practice - squamous cell (49), glandular (66) and small cell (5), revealed the growth of a cancerous tumor in the alveoli. According to a complex of histological and immunohistochemical indicators, it was determined that the growth of the cancerous tumor started from the basement membrane and grew towards the center of the alveolus. When tumor grown to the center of the alveolus, signs of decay of cancer cells were observed, which separated from the solid part of the tumor and fell into necrotic masses, which are the result of the decay of cancer, which is characteristic of a tumor remote from the blood supply.
Conclusions. It has been proven that the main histological types of LC grows in the alveoli and begins from the basal membrane, where the stem cells are located, to the middle of the alveoli. The obtained data are confirmed by the structural, cellular features and the nature of tumor growth in the center of the alveoli, which corresponds to the general patterns of the development of cancer tumors and necrosis with a lack of blood supply.
References
Bolhova, L. Yaroschuk, T. (2010). Gistogenez raka legkogo [Histogenesis of lung cancer]. Voprosy oncology. 56(4), 469-476. [In Russian].
Bolhova, L., Tuganova, T. (2013). Rak legkogo: voprosy gistogeneza i tsitologycheskoi diahnostiki [Lung cancer: issues of histogenesis and cytological diagnostics]. KIM. [In Russian].
Veryovkina, N. (2018). Ostanni dosiahnennia imunoterapii v likuvanni onkolohichnykh patsiientiv: zastosuvannia imunoterapii pry nedribnoklitynnomu raku leheni [Recent advances in immunotherapy in the treatment of cancer patients: the use of immunotherapy in non-small cell lung cancer]. Klinicheskaya onkologiia, 32, 228-231. [In Urkainian].
Ganul, V., Ganul, A., Semivolos, A., Zakharichev, V. et al. (2009). Neoadjuuvantnaia polykhymyoterapiia
bolnykh s nemelkokletochnym rakom legkogo IIB-III stadii [Neoadjuvant polychemotherapy of patients with stage IIB-III non-small cell lung cancer]. Oncology. 11 (3), 197-199. [In Russian].
Erokhin, V., Romanova, L. (2000). Rak legkogo v norme i patologii [Lung cancer in normal and pathology]. Meditsina. [In Russian].
Esipova, I. (1975). Legkoe v norme. [Lung in normal]. Nauka. [In Russian].
Esipova, I. (1975). Legkoe v patologii [Lung in pathology]. Part I. Nauka. [In Russian].
Zagorulko, A., Askary, T. (2002). Atlas ultrastrukturnoj morfologii respiratornogo otdela. [Atlas of ultrastructural morphology of the respiratory department]. AZ-PRESS - SONAT. [In Russian].
Kogan, E., Kodolova, I., Sekamova, S. (1988). Morfogenez perifericheskogo raka legkogo [Morphogenesis of peripheral lung cancer]. Archives of pathology. 50(6), 26-34. [In Russian].
Kogan, E. (1989). Predrak i rak legkogo [Precancer and lung cancer]. Arch. Pathol. 51(11), 76-83. [In Russian].
Kogan, E., Kychygina, O., Demura, S., Osypenko, V. (2012). Morfolohycheskiie, immunogistokhimicheskiie i radiologicheskiie pokazateli legochnoi tkani pri legochnom sarkoidoze [Morphological, immunohistochemical and radiological indicators of lung tissue in pulmonary sarcoidosis]. Arch. Pathol. 74(3), 37-43. [In Russian].
Maksymovich, N. (1980). Patologicheskaia anatomiia ostrykh respiratornykh boleznei i ikh znacheniie v detskoi letalnosti [Pathological anatomy of acute respiratory diseases and their importance in childhood mortality]. Arch. Pathol. 7, 20-24. [In Russian].
Nepomniaschich, G. (2005). Biopsyiia bronkhov: Morfogenez obshchebiologicheskikh protsessov v legkikh [Biopsy of bronchi: Morphogenesis of general biological processes in the lungs]. Moscow, RAMN. [In Russian].
Romanova, L. (1984). Reguliatsiia vosstanovitelnykh protsessov. [Regulation of recovery processes]. Universitet, Moscow. 174 p. [In Russian].
Fedorenko, Z., Mykhailovych, Yu., Goulak, L. (2022). Rak v Ukraini: 2020-2021: Zakhvoriuvanist, smertnist, pokaznyky diialnosti onkolohichnoi sluzhby [Cancer in Ukraine: 2020-2021: Morbidity, mortality, performance indicators of the oncology service]. Biuleten natsionalnoho Kantser-reiestru Ukrainy. Natsionalnyi instytut raku [Bulletin of the National Chancery Register of Ukraine. National Cancer Institute]. 23, 50. [In Urkainian].
Beers, M. F., Moodley, Y. (2017). When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine. American journal of respiratory cell and molecular biology. 57(1), 18-27. DOI: 10.1165/rcmb.2016-0426PS.
Bertoncello, I. (2015). Stem Cells in the Lung. Development, Repair and Regeneration. Springer.
Bolgova, L. S., Tuganova, T. N., Alekseenko, O. I. et al. (2020). Histogenesis of central lung cancer: cytological investigation. Experimental oncology. 42(4), 310-313. DOI: 10.32471/exp-oncology.2312-8852.vol-42-no-4.15232.
Brambilla, E., Trawis, W. D. (2004). Adenosquamous carcinoma. World Health Organization Classification of Tumours. Pathology and genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press.
Chen, Z., Fillmore, C. M., Hammerman, P. S., Kim, C. F., Wong, K. K. (2014). Non-small-cell lung cancers: a heterogeneous set of diseases. Nature reviews. Cancer. 14(8), 535-546. DOI: 10.1038/ nrc3775.
Colby, T. V., Noguchi, M., Henschke, C. (2004). Tumours of the lung. Adenocarcinoma. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. IARC Press.
de Sousa, V., Carvalho, L. (2018). Heterogeneity in Lung Cancer. Pathobiology: journal of immunopathology, molecular and cellular biology. 85(1-2), 96-107. DOI: 10.1159/000487440.
Demura, S. A., Kogan, E. A., Goryachkina, V. L. (2018). Khronicheskie zabolevaniia, predrak i rak legkikh, assotsiirovannye s patologiei bulavovidnykh kletok respiratornykh i terminal'nykh bronkhiol [Chronic diseases, precancer, and cancer of the lung, which are associated with pathology of the club cells of respiratory and terminal bronchioles]. Arkhiv patologii. 80(5), 63-68. DOI: 10.17116/ patol20188005163.
Demura, S. A., Kogan, E. A., Paukov, V. S. (2014). The morphology and molecular bases of damage to the stem cell niche of respiratory acini in idiopathic interstitial pneumonias. Arkhiv patologii. 76(6), 28-36. DOI: 10.17116/patol201476628-36.
Desai, T. J., Brownfield, D. G., Krasnow, M. A. (2014). Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature, 507(7491), 190-194. DOI: 10.1038/nature12930.
Ferone, G., Lee, M. C., Sage, J., Berns, A. (2020). Cells of origin of lung cancers: lessons from mouse studies. Genes & development. 34(15-16), 1017-1032. DOI: 10.1101/gad.338228.120.
Frank, D. B., Penkala, I. J., Zepp, J. A., Sivakumar, A., Linares-Saldana, R., Zacharias, W. J., Stolz, K. G., Pankin, J., Lu, M., Wang, Q., Babu, A., Li, L., Zhou, S., Morley, M. P., Jain, R., Morrisey, E. E. (2019). Early lineage specification defines alveolar epithelial ontogeny in the murine lung. Proceedings of the National Academy of Sciences of the United States of America. 116(10), 4362-4371. DOI: 10.1073/ pnas.1813952116.
Gazdar, A., Franklin, W. A., Brambilla, E. (2004). Genetic and molecular alterations. World Health Organization Classification of Tumours. Pathology and genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press.
Giangreco, A., Reynolds, S. D., Stripp, B. R. (2002). Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. The American journal of pathology. 161(1), 173-182. DOI: 10.1016/S0002-9440(10)64169-7.
Grigoryeva, E. S., Kokova, D. A., Gratchev, A. N., Cherdyntsev, E. S., Buldakov, M. A., Kzhyshkowska, J. G., Cherdyntseva, N. V. (2015). Smoking-related DNA adducts as potential diagnostic markers of lung cancer: new perspectives. Experimental oncology. 37(1), 5-12.
Hanna, J. M., Onaitis, M. W. (2013). Cell of origin of lung cancer. Journal of carcinogenesis. 12, 6. DOI: 10.4103/1477-3163.109033.
Have-Opbroek, A. A., Benfield, J. R., van Krieken, J. H., Dijkman, J. H. (1997). The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas. Histology and histopathology. 12(2), 319-336. DOI: 10.3390/cancers9110155.
Heng, W. S., Gosens, R., Kruyt, F. (2019). Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting. Biochemical pharmacology. 160, 121-133. DOI: 10.1016/j. bcp.2018.12.010.
Hogan, B. L., Barkauskas, C. E., Chapman, H. A., Epstein, J. A., Jain, R., Hsia, C. C., Niklason, L., Calle, E., Le, A., Randell, S. H., Rock, J., Snitow, M., Krummel, M., Stripp, B. R., Vu, T., White, E. S., Whitsett, J. A., Morrisey, E. E. (2014). Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. Cell stem cell. 15(2), 123-138. DOI: 10.1016/j. stem.2014.07.012.
Kadota, K., Kushida, Y., Kagawa, S., Ishikawa, R., Ibuki, E., Inoue, K., Go, T., Yokomise, H., Ishii, T., Kadowaki, N., Haba, R. (2019). Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces. The American journal of surgical pathology. 43(8), 1033-1041. DOI: 10.1097/ PAS.0000000000001285.
Kim, C. F., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley,D., Bronson, R. T., Jacks, T. (2005). Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 121(6), 823-835. DOI: 10.1016/j. cell.2005.03.032.
Navarro, S., Driscoll, B. (2017). Regeneration of the Aging Lung: A Mini-Review. Gerontology. 63(3), 270-280. DOI: 10.1159/000451081.
Netter, F. (2019). Atlas of human anatomy. 7 ed. Elsevier.
Pennycuick, A., Janes, S. M. (2020). On the Origin of Lung Cancers. American journal of respiratory and critical care medicine. 201(6), 646647. DOI: 10.1164/rccm.201911-2176ED.
Sainz de Aja, J., Dost, A., Kim, C. F. (2021). Alveolar progenitor cells and the origin of lung cancer. Journal of internal medicine. 289(5), 629-635. DOI: 10.1111/joim.13201.
Salahudeen, A. A., Choi, S. S., Rustagi, A., Zhu, J., van Unen, V., de la O, S. M., Flynn, R. A., Margalef-Catala, M., Santos, A., Ju, J., Batish, A., Usui, T., Zheng, G., Edwards, C. E., Wagar, L. E., Luca, V., Anchang, B., Nagendran, M., Nguyen, K., Hart, D. J., Kuo, C. J. (2020). Progenitor identification and SARS-CoV-2 infection in human distal lung organoids. Nature. 588(7839), 670-675. DOI: 10.1038/ s41586-020-3014-1.
Semenova, E. A., Nagel, R., Berns, A. (2015). Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes & development. 29(14), 1447-1462. DOI: 10.1101/gad.263145.115.
Situ, D., Wang, J., Ma, Y., Zhu, Z., Hu, Y., Long, H., Rong, T. (2011). Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer. Medical oncology. 28 Suppl 1, S596-S604. DOI: 10.1007/s12032-010-9752-4.
Sneddon, J. B., Werb, Z. (2007). Location, location, location: the cancer stem cell niche. Cell stem cell. 1(6), 607-611. DOI: 10.1016/j.stem.2007.11.009.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians. 71(3), 209-249. DOI: 10.3322/caac.21660.
Sutherland, K. D., Berns, A. (2010). Cell of origin of lung cancer. Molecular oncology. 4(5), 397403. DOI: 10.1016/j.molonc.2010.05.002.
Travis, W. D., Brambilla, E., Burke, A. P. (2015). World Health Organization Classification of Tumours. Pathology and genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press.
Travis, W., Nicholson, S., Hirsch, F. R. (2004). Small cell carcinoma. World Health Organization Classification of Tumours. Pathology and genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, 31-34.
Weibel, E. R. (1970). Morphometry of human lungs. Medicina.
Xu, J., Yu, Q., Liu, X. (1998). Proximal bronchial invasion of lung cancer: a clinicopathological study. Cancer research. Zhonghua zhong liu za zhi [Chinese journal of oncology]. 20(6), 448-450.
Yagi, Y., Aly, R. G., Tabata, K., Barlas, A., Rekhtman, N., Eguchi, T., Montecalvo, J., Hameed, M., Manova-Todorova, K., Adusumilli, P. S., Travis, W. D. (2020). Three-Dimensional Histologic, Immunohistochemical, and Multiplex Immunofluorescence Analyses of Dynamic Vessel Co-Option of Spread Through Air Spaces in LungAdenocarcinoma. Journal of thoracic oncology. Official publication of the International Association for the Study of Lung Cancer. 15(4), 589-600. DOI: 10.1016/j.jtho.2019.12.112.
Zamay, T. N., Zamay, G. S., Kolovskaya, O. S., Zukov, R. A., Petrova, M. M., Gargaun, A., Berezovski, M. V., Kichkailo, A. S. (2017). Current and Prospective Protein Biomarkers of Lung Cancer. Cancers. 9(11), 155. DOI: 10.3390/cancers9110155.
Downloads
Published
How to Cite
Issue
Section
License
Journal Medical Informatics and Engineering allows the author(s) to hold the copyright without registration
The majority of Medical Informatics and Engineering Open Access journals publish open access articles under the terms of the Creative Commons Attribution (CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited. The remaining journals offer a choice of licenses.
This journal is available through Creative Commons (CC) License CC-BY 4.0
